What is the recommended antibiotic dose and duration for treating otomastoiditis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Antibiotic Treatment for Otomastoiditis

For otomastoiditis, cloxacillin/flucloxacillin should be administered intravenously at 50 mg/kg four times daily for 10 days as first-line treatment. 1

First-Line Treatment Options

The World Health Organization (WHO) Pocket Book of Hospital Care for Children provides clear guidance for treating otomastoiditis:

  • First-line therapy: Cloxacillin/flucloxacillin IV at 50 mg/kg QDS (four times daily) for 10 days 1
  • Second-line therapy: Ceftriaxone IV 1

Clinical Presentation and Diagnosis

Otomastoiditis typically presents with:

  • Retroauricular swelling, erythema, and tenderness
  • Displacement of the pinna
  • Otomicroscopic evidence of acute otitis media
  • Refractory otorrhea in many cases 2

Treatment Algorithm

Step 1: Initial Management

  • Intravenous antibiotics: Begin with cloxacillin/flucloxacillin 50 mg/kg QDS 1
  • Surgical intervention: Consider myringotomy for drainage, especially in cases not responding to initial antibiotic therapy within 48 hours 3

Step 2: Monitoring Response

  • Assess clinical improvement within 48-72 hours
  • If no improvement is seen, consider:
    • Changing to second-line therapy (ceftriaxone)
    • Surgical intervention

Step 3: Surgical Considerations

  • Mastoidectomy should be performed in patients with:
    • Acute coalescent mastoiditis
    • Evidence of intracranial complications
    • Failure to respond to medical management 3

Special Considerations

Outpatient Management

In select cases, outpatient management may be considered:

  • Once-daily IM ceftriaxone has been used successfully in children with acute mastoiditis with periosteitis
  • This approach requires daily evaluation by specialists and careful patient selection 2

Complications

Potential complications requiring more aggressive management include:

  • Intracranial extension (brain abscess, meningitis)
  • Sigmoid sinus thrombosis
  • Facial nerve palsy
  • Labyrinthitis 3

Microbiology

Common pathogens in otomastoiditis include:

  • Streptococcus pneumoniae
  • Streptococcus pyogenes
  • Staphylococcus aureus 4

This is why anti-staphylococcal coverage with cloxacillin/flucloxacillin is recommended as first-line therapy.

Pitfalls to Avoid

  1. Inadequate duration of therapy: The full 10-day course is essential for complete eradication of infection 1

  2. Delayed surgical intervention: Failure to consider surgical drainage when antibiotics are not producing improvement within 48 hours can lead to complications 3

  3. Overlooking resistant organisms: In cases of treatment failure, obtain cultures to guide antibiotic selection 4

  4. Insufficient imaging: CT scanning should be performed when there is clinical suspicion of coalescent mastoiditis or intracranial complications 5

  5. Premature discontinuation of IV antibiotics: Ensure complete resolution of acute inflammation before considering transition to oral therapy

In refractory cases, particularly those with unusual presentations or treatment failures, consider the possibility of nontuberculous mycobacterial infection, which requires specialized treatment approaches 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Outpatient management of acute mastoiditis with periosteitis in children.

International journal of pediatric otorhinolaryngology, 1998

Research

Acute mastoiditis: a 10 year retrospective study.

International journal of pediatric otorhinolaryngology, 2002

Research

Acute mastoiditis--the antibiotic era: a multicenter study.

International journal of pediatric otorhinolaryngology, 2001

Research

Emergence of Refractory Otomastoiditis Due to Nontuberculous Mycobacteria: Institutional Experience and Review of the Literature.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.